DK0413667T3 - Halogenalkylphenyl-alkoholer, ketoner og hydrater deraf - Google Patents

Halogenalkylphenyl-alkoholer, ketoner og hydrater deraf

Info

Publication number
DK0413667T3
DK0413667T3 DK90810608.1T DK90810608T DK0413667T3 DK 0413667 T3 DK0413667 T3 DK 0413667T3 DK 90810608 T DK90810608 T DK 90810608T DK 0413667 T3 DK0413667 T3 DK 0413667T3
Authority
DK
Denmark
Prior art keywords
haloalkylphenyl
hydrates
ketones
alcohols
therapeutics
Prior art date
Application number
DK90810608.1T
Other languages
English (en)
Inventor
Sylvain Cottens
Original Assignee
Sandoz Ag
Sandoz Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sandoz Ag, Sandoz Ltd filed Critical Sandoz Ag
Application granted granted Critical
Publication of DK0413667T3 publication Critical patent/DK0413667T3/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C225/00Compounds containing amino groups and doubly—bound oxygen atoms bound to the same carbon skeleton, at least one of the doubly—bound oxygen atoms not being part of a —CHO group, e.g. amino ketones
    • C07C225/22Compounds containing amino groups and doubly—bound oxygen atoms bound to the same carbon skeleton, at least one of the doubly—bound oxygen atoms not being part of a —CHO group, e.g. amino ketones having amino groups bound to carbon atoms of six-membered aromatic rings of the carbon skeleton
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C215/00Compounds containing amino and hydroxy groups bound to the same carbon skeleton
    • C07C215/02Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton
    • C07C215/22Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being unsaturated
    • C07C215/28Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being unsaturated and containing six-membered aromatic rings
    • C07C215/30Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being unsaturated and containing six-membered aromatic rings containing hydroxy groups and carbon atoms of six-membered aromatic rings bound to the same carbon atom of the carbon skeleton
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00Drugs for disorders of the muscular or neuromuscular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/18Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C225/00Compounds containing amino groups and doubly—bound oxygen atoms bound to the same carbon skeleton, at least one of the doubly—bound oxygen atoms not being part of a —CHO group, e.g. amino ketones
    • C07C225/02Compounds containing amino groups and doubly—bound oxygen atoms bound to the same carbon skeleton, at least one of the doubly—bound oxygen atoms not being part of a —CHO group, e.g. amino ketones having amino groups bound to acyclic carbon atoms of the carbon skeleton
    • C07C225/14Compounds containing amino groups and doubly—bound oxygen atoms bound to the same carbon skeleton, at least one of the doubly—bound oxygen atoms not being part of a —CHO group, e.g. amino ketones having amino groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being unsaturated
    • C07C225/16Compounds containing amino groups and doubly—bound oxygen atoms bound to the same carbon skeleton, at least one of the doubly—bound oxygen atoms not being part of a —CHO group, e.g. amino ketones having amino groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being unsaturated and containing six-membered aromatic rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C225/00Compounds containing amino groups and doubly—bound oxygen atoms bound to the same carbon skeleton, at least one of the doubly—bound oxygen atoms not being part of a —CHO group, e.g. amino ketones
    • C07C225/20Compounds containing amino groups and doubly—bound oxygen atoms bound to the same carbon skeleton, at least one of the doubly—bound oxygen atoms not being part of a —CHO group, e.g. amino ketones having amino groups bound to carbon atoms of rings other than six-membered aromatic rings of the carbon skeleton
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2602/00Systems containing two condensed rings
    • C07C2602/02Systems containing two condensed rings the rings having only two atoms in common
    • C07C2602/04One of the condensed rings being a six-membered aromatic ring
    • C07C2602/10One of the condensed rings being a six-membered aromatic ring the other ring being six-membered, e.g. tetraline

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Biomedical Technology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Pain & Pain Management (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
DK90810608.1T 1989-08-16 1990-08-14 Halogenalkylphenyl-alkoholer, ketoner og hydrater deraf DK0413667T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE3927049A DE3927049A1 (de) 1989-08-16 1989-08-16 Halogenalkyl-phenyl-ketone und deren hydrate, ihre herstellung und verwendung

Publications (1)

Publication Number Publication Date
DK0413667T3 true DK0413667T3 (da) 1993-11-08

Family

ID=6387229

Family Applications (1)

Application Number Title Priority Date Filing Date
DK90810608.1T DK0413667T3 (da) 1989-08-16 1990-08-14 Halogenalkylphenyl-alkoholer, ketoner og hydrater deraf

Country Status (18)

Country Link
US (1) US5166181A (da)
EP (1) EP0413667B1 (da)
JP (1) JPH03101643A (da)
KR (1) KR910004539A (da)
AT (1) ATE95166T1 (da)
AU (1) AU632844B2 (da)
CA (1) CA2023233A1 (da)
CZ (1) CZ411391A3 (da)
DE (2) DE3927049A1 (da)
DK (1) DK0413667T3 (da)
ES (1) ES2060127T3 (da)
FI (1) FI904025A7 (da)
HU (1) HUT58686A (da)
IE (1) IE902938A1 (da)
IL (1) IL95370A0 (da)
NZ (1) NZ234902A (da)
PT (1) PT94997A (da)
ZA (1) ZA906506B (da)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5336675A (en) * 1991-05-14 1994-08-09 Ernir Snorrason Method of treating mania in humans
EP0627400A1 (en) * 1993-06-04 1994-12-07 Merrell Dow Pharmaceuticals Inc. Aromatic acetylcholinesterase inhibitors
US6673784B1 (en) 1996-03-19 2004-01-06 G. D. Searle & Co. Electrophilic ketones for the treatment of herpesvirus infections
DE69715606T2 (de) * 1996-03-19 2003-05-08 G.D. Searle & Co., Chicago Elektrophile ketone zur behandlung von herpesvirus-infectionen
US6218383B1 (en) 1998-08-07 2001-04-17 Targacept, Inc. Pharmaceutical compositions for the prevention and treatment of central nervous system disorders
IT1304904B1 (it) 1998-09-11 2001-04-05 Eisai Co Ltd Derivati anticolinesterasici per il trattamento delle sindromidolorose funzionali e/o organiche
JP4639042B2 (ja) * 2003-09-29 2011-02-23 富士フイルムファインケミカルズ株式会社 ハロゲン−リチウム交換反応を用いる有機化合物の製造法
EP2044937A4 (en) 2006-07-05 2010-10-27 Tianjin Hemay Bio Tech Co Ltd ANALGESIC DERIVATIVES 5,9 - METHANOCYCLO OCTA (B) PYRIDINE - 2 (1H) - ONE, PROCESS FOR PREPARING SAME AND USE THEREOF
US20110212928A1 (en) 2010-02-09 2011-09-01 The Johns Hopkins University Methods and compositions for improving cognitive function
WO2014078568A1 (en) 2012-11-14 2014-05-22 The Johns Hopkins University Methods and compositions for treating schizophrenia
WO2014144663A1 (en) 2013-03-15 2014-09-18 The Johns Hopkins University Methods and compositions for improving cognitive function
EP2968220B1 (en) 2013-03-15 2021-05-05 Agenebio, Inc. Methods and compositions for improving cognitive function
NZ738682A (en) 2015-05-22 2022-01-28 Agenebio Inc Extended release pharmaceutical compositions of levetiracetam

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2840617A (en) * 1954-10-25 1958-06-24 Shell Dev New polyols, their preparation and derivatives
DE1934130A1 (de) * 1968-07-26 1970-01-29 Boehringer Sohn Ingelheim Acylphenylalkylamine und ihre Herstellung
US3996279A (en) * 1973-01-02 1976-12-07 Gerot-Pharmazeutika Dr. Walter Otto K.G. Novel 2-amino methyl-4,6-dihalogenphenol derivatives and methods for the preparation thereof
US4211794A (en) * 1979-01-08 1980-07-08 Pfizer Inc. N,N-Disubstituted aminomethylphenylethanolamines
JPS62252737A (ja) * 1986-04-01 1987-11-04 Japan Tobacco Inc アルデヒドまたはケトンのアルコールへの還元方法
EP0432719A1 (en) * 1989-12-14 1991-06-19 Hoechst-Roussel Pharmaceuticals Incorporated Alkylamino- and alkylaminoalkyl diarylketones, a process for their preparation and their use as medicaments

Also Published As

Publication number Publication date
AU6101590A (en) 1991-02-21
EP0413667B1 (de) 1993-09-29
IE902938A1 (en) 1991-02-27
CA2023233A1 (en) 1991-02-17
HUT58686A (en) 1992-03-30
EP0413667A1 (de) 1991-02-20
CZ411391A3 (en) 1994-01-19
FI904025A7 (fi) 1991-02-17
ATE95166T1 (de) 1993-10-15
HU904868D0 (en) 1991-01-28
KR910004539A (ko) 1991-03-28
IL95370A0 (en) 1991-06-30
FI904025A0 (fi) 1990-08-14
US5166181A (en) 1992-11-24
ZA906506B (en) 1992-04-29
NZ234902A (en) 1993-01-27
DE59002905D1 (de) 1993-11-04
AU632844B2 (en) 1993-01-14
PT94997A (pt) 1991-04-18
DE3927049A1 (de) 1991-02-21
JPH03101643A (ja) 1991-04-26
ES2060127T3 (es) 1994-11-16

Similar Documents

Publication Publication Date Title
ES525653A0 (es) Procedimiento para preparar nuevos diazabiciclo-(3.3.1)-nonanos
IT1188889B (it) Impiego di benzofuran-2-oni e/o in dolin-2-oni come antiossidanti
ES2124793T3 (es) Derivados de rapamicina alquilados en o y su uso, particularmente como inmunosupresores.
AR223455A1 (es) Composiciones fungicidas que contienen derivados de n-(3-(p-ter.butil-fenil)o 3-(p-ter.butilciclohexil)-2-metilpropil o-2-metilprop-2-enil)-morfolina o piperidina y sus n-oxidos,estos compuestos para su exclusivo uso en dichas composiciones y procedimiento para su preparacion
DK520784D0 (da) Cycliske polypeptider, deres fremstilling og anvendelse
BG31496A3 (bg) Метод за получаване на 4-амино-5-алкил-сулфонил ортоанизамиди
FI904025A0 (fi) Halogenalkylfenylalkoholer.
DK301980A (da) Nikkomyciner i,j, og n, deres fremstilling og anvendelse
DK0598770T3 (da) Pyrazinderivater samt fremstilling og anvendelse deraf
IT1113390B (it) Copolimero ad innesto utile nella elettrodeposizione
DK0386451T3 (da) Oxiderede diphenylheteroalkaner, fremgangsmåde til fremstilling heraf og anvendelsen af disse
DK23386D0 (da) Pyridopyrimidiner, deres fremstilling og anvendelse som laegemidler
IT8024192A0 (it) Composizioni dermatologiche erelativo procedimento di preparazione.
GR3006834T3 (da)
DK243280A (da) 3,4,5-trihydroxypiperidinderivater deres fremstilling og anvendelse
DE69100517D1 (de) Polyethyleneiminphosphonatderivate als Dispergiermittel enthaltende Zementzusammensetzungen.
DK401482A (da) Alkylsulfoner, deres fremstilling og anvendelse
FR2622103B1 (fr) Nouvelles compositions dermatologiques bronzantes insectifuges
DK286480A (da) Oxinethere deres fremstilling og anvendelse
DK313587D0 (da) Tetrahydrobenzothiazolforbindelser, deres fremstilling og anvendelse
BG32116A3 (bg) Метод за получаване на 4''-амино-олеандомицинови производни
DK194981A (da) Hudpraeparat
DK4679A (da) Carbamoyltriazolyl-o,n-acetaler deres fremstilling og anvendelse
DK0617027T3 (da) N-benzylpiperazinforbindelser, fremgangsmåde til fremstilling heraf og sammensætninger indeholdende forbindelserne
ATE111099T1 (de) Ergolinderivate.